Shares of Hamilton Thorne Ltd. (CVE:HTL – Get Free Report) traded up 4.3% during mid-day trading on Monday . The company traded as high as C$1.45 and last traded at C$1.45. Approximately 25,700 shares changed hands during trading, a decline of 27% from the average daily volume of 35,118 shares. The stock had previously closed at C$1.39.
Hamilton Thorne Stock Performance
The company has a current ratio of 2.04, a quick ratio of 2.25 and a debt-to-equity ratio of 43.24. The firm’s fifty day moving average is C$1.45 and its 200 day moving average is C$1.45. The company has a market cap of C$149.69 million, a PE ratio of 58.94 and a beta of 0.54.
About Hamilton Thorne
Hamilton Thorne Ltd. develops, manufactures, and sells precision instruments, consumables, software, and services for the assisted reproductive technologies (ART), research, and cell biology markets. It offers precision laser systems, imaging systems, and other equipment and consumables for the ART and developmental biology research markets. The company also provides test laboratory and endotoxin testing services, as well as sperm assays, including Sperm Motility Index and Sperm Penetration; and fresh and cryopreserved mouse embryos supply, and technician training and proficiency testing services.
Further Reading
- Five stocks we like better than Hamilton Thorne
- 3 Gold Stocks Under $5 With Massive Upside
- Blueprint for a Billion: Nebius Group Secures the AI Floor
- As the Iran War Resumes, 2 Energy ETFs Ride Oil’s Renewed Rally
- Tower Semiconductor’s AI Rally Is Built on a Light-Speed Bet
Receive News & Ratings for Hamilton Thorne Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hamilton Thorne and related companies with MarketBeat.com's FREE daily email newsletter.
